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HYDROXYUREA is a cytotoxic drug which has recently been investigated as a
therapeutic agent in a number ofmalignant conditions, e.g. cancer ofthe head and
neck (Beckloff, 1967), and leukaemia especially chronic myeloid leukaemia
(Malpas, 1967; Weil and Tanzer, 1967). It is not a new compound but has only
recently beenscreenedforactivityagainst cancer. Itisbelievedthattheactivity of
hydroxyurea is due to an immediate inhibition of DNA synthesis without,
apparently, inhibition of RNA or protein synthesis. Yarbro (1965) showed that
hydroxyurea prevented the incorporation of 32p into the DNA of ascites tumour
cells while having only a slight effect on the incorporation of 32p into RNA. An
attempt has been made to determine, by the use of phytohaemagglutinin-
stimulated lymphocyte cultures, the concentration of the drug necessary for
cytotoxic and antimitotic activity.
MATERIALS AND METHODS
Venous blood samples from healthy volunteers, with no history of treatment
with hydroxyurea or other cytotoxic drug, were mixed immediately with anti-
coagulant (heparin in dextran) and the erythrocytes were allowed to settle. The
supernatant plasma and cells were drawn off and set up as 10 ml. cultures with
TC199 (Glaxo). Hydroxyurea in TC199 was added to each culture to give the
final concentrations shown in Table I. Control cultures were set up at the same
TABLE I.-The Effects of Various Concentrations ofHydroxyurea on Cells in Culture
Mg. hydroxyurea % cells Equivalent to
per 10 ml. culture in mitosis a dose rate of
(mg. per kg.)
8-0 . 0 . 800
0-8 . 0 . 80
8x 10-2 . 16*S . 8
8x 10-3 . 23-2 . 0-8
8 x10-4 37 - 9 . x10-2
8 x 1-5 . 92 - 9 .8 x 10-3
8 x 10-6 . 85-7 .8 x 1O-4
8 x 1O-7 89- 3 .8 x 1-5
0 . 100-0 .
(Control)
time. All cultures were incubated at 370 C. for 72 hours after the addition of
two drops of reconstituted PHA-P (Difco). At the end of this time 0 2 ml. of
colcemid (Demecolcine), at a concentration of 1 mg. per 100 ml. of TC199, wasJ. TIMSON
added to each culture to arrest mitosis and the cultures were incubated for a
further 2 hours at 370 C. After this time the cells were spun down andresuspended
in hypotonic saline for 15 minutes at 370 C. They were then fixed with acetic
alcohol twice, spread onto cold slides air-dried and stained with Giemsa's stain
at pH 6-4. One thousand cells per culture were examined and the number of
cells in mitosis noted. This figure was expressed as a percentage of the control
value. Each estimation was performed in duplicate.
RESULTS
The results given in Table I indicate that, at concentrations of 0.8 mg. per
10 ml. and above, hydroxyurea is lethal to cells and in these cultures few lympho-
cytes had transformed in response to the PHA. Between 8 x 10-2 and 8 X 10-4
mg. per 10 ml. the drug is not cytotoxic but is antimitotic, while at 8 x 10-5 mg.
per 10 ml. and below no significant activity ofeither type was observed. Cultures
in which 8-0 and 0-8 mg. of urea per 10 ml. were present gave mitotic indices of
60-3 % and 61-8 % of control, respectively, showing that urea was not cytotoxic
at these concentrations but caused some depression of mitosis.
DISCUSSION
Hydroxyurea is a derivative of urea in which one of the hydrogen atoms is
replaced by an hydroxyl group. The usual effect of the introduction of an
hydroxyl group into an aliphatic compound is a reduction of its physiological
activity and toxicity and this reduction is more or less proportional in many cases
to the number ofhydroxyl groups incorporated, e.g. aldehydes -+ aldols --- aldoses.
In aromatic compounds, however, the addition of an hydroxyl group often
increases the toxicity of the compound, e.g. benzene -- phenol and its physio-
logical activity, e.g. benzoic acid -÷ salicylic acid. Exceptions to these general
rules exist, of course, in particular ethylene glycol is far more toxic than ethyl
alcohol. Hydroxyurea, being an aliphatic compound and having a much greater
toxicity than urea, appears to be another exception to the general rule. It has
been suggested that the hydroxyl group does not have activity in itselfbut acts as
an anchoring group. Since the available evidence suggests that hydroxyurea acts
by inhibition of DNA synthesis, it may be that this inhibition is caused by the
attachment of the hydroxyurea to some part of the DNA during replication.
As there is also evidence that RNA synthesis is not interfered with, it seems
reasonable to suggest that hydroxyurea may be able to become attached to
thymine in DNA but not to uracil in RNA.
Beckloff (1967) found that the half life for serum levels of hydroxyurea after
80 mg. per kg. doses was about 5 hours and that after 24 hours only negligible
amounts were present. He also reported that the rapid clearing of serum levels
was produced by rapid excretion, 45 % of a single dose being excreted unchanged
in the urine. From these figures and from Table I it will be seen that with high
doses (80 mg. per kg.) the hydroxyurea levels will be cytotoxic for only a relatively
short time; they will then be antimitotic for a rather longer time and then inactive.
It is perhaps for this reason that Beckloff (1967) found 80 mg. per kg. every 3 days
a satisfactory regime. Malpas (1967), after an initial daily dosage of 20-30 mg.
per kg., reduced quickly to 500 mg. daily, which would be 6 to 8 mg. per kg. and
which, from Table I, would be strongly antimitotic but not cytotoxic.
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While it must be remembered that extrapolation from PHA-stimulated
lymphocytes to cancer cells is somewhat speculative, it is hoped that the results
given here may be of some help to clinicians using hydroxyurea.
SUMMARY
The cytotoxic and antimitotic activity of hydroxyurea on PHA-stimulated
human lymphocytes in vitro has been investigated. It has been shown that with
these cells there is a definite threshold concentration above which mitosis is
progressively inhibited and a second threshold above which the drug is cytotoxic.
The possible mechanisms by which this occurs and its relevance to the use of the
drug are briefly discussed.
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